HICCC member Dr. Raul Rabadan has authored a new book, Understanding Coronavirus, to provide readers an accessible overview about the novel virus and COVID-19 pandemic.
Congratulations to Dr. Xuebing Wu, who was just named a 2020 Pew-Stewart Scholar for innovative cancer research by the Pew Charitable Trusts and the Alexander and Margaret Stewart Trust.
Two new pilot grants awarded by the Herbert Irving Comprehensive Cancer Center and Columbia Engineering are combining the strengths of cancer and engineering disciplines to problem solve the disease.
Led by Dr. Alexander Melamed, a new study confirms minimally invasive surgery for early-stage cervical cancer is linked to higher rates of recurrence and death compared with open surgery.
OPTIC provides researchers access to a broad range of in vivo imaging technologies that can help advance our understanding of how cancer progresses, and accelerate translational research.
Data reported by HICCC researchers at ASCO concluded more frequent mammographic screening among early-stage breast cancer patients might not confer additional benefit at the expense of potential harm.
The MCSR at the HICCC provides a wide range of technology platforms and services–from classical cytogenetics and high throughput imaging analyses to sequence-based assessment of DNA damage and repair.
In a new study, a multi-disciplinary team led by investigators at CUIMC has unraveled the epigenomic underpinnings of the Warburg effect in glioblastoma.
